DR
Dr. Reddy’s Laboratories Ltd ADR
🇺🇸XNYS.RDYUnited StatesHealthcare
$11.62USDup +0.08 (+0.69%)OpenDelayed5:14 PM
Price$11.62+0.08 (+0.69%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- United States
Identity
- Exchange
- New York Stock Exchange . XNYS
- Type
- Stock
- ISIN
- US2561352038
- CUSIP
- 256135203
Company
- Employees
- 27,527
- Headquarters
- Hyderabad, United States
- Website
- https://www.drreddys.com
- CEO
- Mr. Deepak Sapra M.B.A.
Market
- Shares outstanding
- 833M
- Market cap
- $9.68B
Key dates
- Next earnings
- Oct 23, 2026
Highlights
- Market cap
- $9.61B
- EPS LTM
- ₹39.83
- P/E LTM
- 34.12
- Div yield
- 0.6%
Fundamentals (LTM)
- Revenue
- ₹332.83B-0.43%down year on year
- Net income
- ₹33.17B-41.61%down year on year
- Gross margin
- 50.15%-13.01%down year on year
- Free cash flow
- ₹15.15B+4.89%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.